IRulya Therapeutics (IRLA) Sale and Maturity of Investments (2019 - 2026)
IRulya Therapeutics (IRLA) recorded Sale and Maturity of Investments - Total of $12 million in Q1 2026, down 7.7% from $13 million a year earlier and down 7.7% from the prior quarter.
Powered by 
Analysis
IRulya Therapeutics (IRLA) Sale and Maturity of Investments (2019 - 2026) Analysis & Trends
For FY2025, IRulya Therapeutics reported Sale and Maturity of Investments - Total of $58 million, down 48.1% from FY2024.
- Annual Sale and Maturity of Investments - Total has a five-year compound annual growth rate of -15.5% (FY2020 to FY2025).
- Across earlier years, Sale and Maturity of Investments - Total came in at $111.73 million in FY2024 (+0.5%), $111.21 million in FY2023 (+34.8%), $82.49 million in FY2022 (-15.8%) and $97.92 million in FY2021 (-27.3%).
- The Q1 2026 figure is the lowest quarterly Sale and Maturity of Investments - Total since Q4 2024.
- On a year-over-year basis, Sale and Maturity of Investments - Total rose in three of the last eight quarters, with an average decline of 17.6%.
- Peak year-over-year performance for Sale and Maturity of Investments - Total in the last five years was growth of 263.4% in Q1 2024, against a decline of 79.1% in Q3 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at $13 million (Q4 2025), $14 million (Q3 2025) and $18 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Investments Sold (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 308.00 Mn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | - |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 405.00 Mn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | 88.00 Mn |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | - |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 2.53 Bn |
| 10 | IRulya Therapeutics | 207.35 Mn | 91.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 12.00 Mn |
| Dec 31, 2025 | 13.00 Mn |
| Sep 30, 2025 | 14.00 Mn |
| Jun 30, 2025 | 18.00 Mn |
| Mar 31, 2025 | 13.00 Mn |
| Dec 31, 2024 | 11.00 Mn |
| Sep 30, 2024 | 10.99 Mn |
| Jun 30, 2024 | 41.49 Mn |
| Mar 31, 2024 | 48.25 Mn |
| Dec 31, 2023 | 26.70 Mn |
| Sep 30, 2023 | 49.12 Mn |
| Jun 30, 2023 | 22.12 Mn |
| Mar 31, 2023 | 13.28 Mn |
| Dec 31, 2022 | 27.00 Mn |
| Sep 30, 2022 | 21.11 Mn |
| Jun 30, 2022 | 12.01 Mn |
| Mar 31, 2022 | 22.38 Mn |
| Dec 31, 2021 | 23.97 Mn |
| Sep 30, 2021 | 11.38 Mn |
| Jun 30, 2021 | 18.91 Mn |
API Access
IRulya Therapeutics Sale and Maturity of Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=IRLA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "sale-and-maturity-of-investments", "ticker": "IRLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=IRLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();